Maria Mora Pinzon, MD, MS, spoke to Telemundo Wisconsin about the approval of Alzheimer’s disease treatment ‘Leqembi’ (lecanemab) on July 14, 2023. The medication was fully approved by the U.S. Food and Drug Administration (FDA) on July 6, 2023.
Read the FDA statement about lecanemab approval.
“Que Pasa Wisconsin: Información sobre ‘Leqembi’ nuevo medicamento contra el Alzheimer” – Telemundo Wisconsin, July 14, 2023